- Investing Ideas
- French Pharmaceuticals & Biotech Breakout Stocks
French Pharmaceuticals & Biotech Breakout Stocks
Results
3
Stocks where the price continues to rise after more than a year of consistent gains.
3 companies
ABIVAX Société Anonyme
Market Cap: €10.8b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€135.00
7D
59.8%
1Y
1,820.3%
Genfit
Market Cap: €644.4m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€12.94
7D
27.4%
1Y
288.8%
Valerio Therapeutics Société anonyme
Market Cap: €254.7m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.51
7D
159.1%
1Y
672.7%